This is a very useful quick reference guide to first and second-line TB drugs from the WRHI.
This reference is also available as a PDF file.
A
Quick Reference to Drugs commonly used in the Management of TB
ORAL
AGENTS
– 1st
line
|
NAME
|
RIFAMPICIN
(Bactericidal,
Sterilizing)
|
|
DOSE/KG
|
10
mg/kg/day
|
|
USUAL
DOSE
|
600
mg dly
|
|
MAXIMUM
DOSE
|
600
mg dly
|
|
CAUTION
|
Hepatic
disease, alcoholism, porphyria, hypersensitivity to Rifampicin
|
|
COMMON
SIDE EFFECTS
|
↑ ALT,
GI , Hypersensitivity, Orange discoloration of body fluids
|
|
PAEDIATRIC
DOSE
|
10
mg/kg/day
(up
to
20
mg/kg/day
for
TBM/Miliary
TB)
|
|
RENAL
DOSE
|
N/A
|
|
LIVER
IMPAIRMENT DOSE
|
8
mg/kg/day
|
|
PREGNANCY
|
Category
C
|
|
LACTATION
|
Amount
excreted too small to harm
|
|
BUILDING
A
REGIMEN
|
High
early
bactericidal
activity.
With
Isoniazid
achieves
greater
killing
than
either
drug
alone.
Resistance
more
rare
than
Isoniazid
resistance
|
|
NAME
|
ISONIAZID
(Bactericidal)
|
|
DOSE/KG
|
5
mg/kg/day
(10
mg/kg/day
=
High
dose
INH)
|
|
USUAL
DOSE
|
300
mg dly
|
|
MAXIMUM
DOSE
|
300
mg dly
|
|
CAUTION
|
Hepatic
disease, Epilepsy, hypersensitivity to Isoniazid, porphyria
|
|
COMMON
SIDE EFFECTS
|
Skin
rash,
peripheral
neuropathy,
↑ ALT,
neurotoxicity,
haematological
effects
|
|
PAEDIATRIC
DOSE
|
5-10
mg/kg/day (up to 15 mg/kg/day for TBM/Miliary TB)
|
|
RENAL
DOSE
|
N/A
|
|
LIVER
IMPAIRMENT DOSE
|
N/A
|
|
PREGNANCY
|
Category
C
|
|
LACTATION
|
Monitor
infant for adverse effects
|
|
BUILDING
A REGIMEN
|
Highest
early
bactericidal
activity.
With
Rifampicin
achieves
greater
killing
than
either
drug
alone.
Strain
of
TB
may
still
be
susceptible
in
certain
cases
of
resistance
depending
on
mutation
|
|
NAME
|
PYRAZINAMIDE
(Sterilizing)
|
|
DOSE/KG
|
20-30
mg/kg/day
|
|
USUAL
DOSE
|
1600
mg dly
|
|
MAXIMUM
DOSE
|
2
g dly
|
|
CAUTION
|
Gout,
Hepatic disease, Diabetes, Renal impairment, hypersensitivity to
pyrazinamide, isoniazid, ethionamide or niacin, porphyria
|
|
COMMON
SIDE EFFECTS
|
Hepatotoxicity,
arthralgia
(hyperuricaemia),
GI
side
effects,
skin
rash
|
|
PAEDIATRIC
DOSE
|
15-30
mg/kg/day (up to 40 mg/kg/day for TBM/Miliary TB)
|
|
RENAL
DOSE
|
Use
doses at lower limit of recommended range. GFR<10 ml/min –
↓dose by 50%
|
|
LIVER
IMPAIRMENT DOSE
|
Avoid
drug if possible
|
|
PREGNANCY
|
Category
C
|
|
LACTATION
|
No
problems with usage
|
|
BUILDING
A REGIMEN
|
Good
sterilizing
activity,
contributes
to
shortening
of
duration
of
treatment.
Resistance
not
tested
routinely
|
|
NAME
|
ETHAMBUTOL
(Bacteriostatic,
may
be
bactericidal
at
high
doses)
|
|
DOSE/KG
|
15-20
mg/kg/day
|
|
USUAL
DOSE
|
800
mg
dly
|
|
MAXIMUM
DOSE
|
1000
mg
dly
|
|
CAUTION
|
Eye
defects, renal disease or hyperuricaemia
|
|
COMMON
SIDE EFFECTS
|
Ocular
toxicity, arthralgia (hyperuricaemia), GI side effects
|
|
PAEDIATRIC
DOSE
|
15-25
mg/kg/day
(up
to
15
mg/kg/day
for
TBM/Miliary
TB)
|
|
RENAL
DOSE
|
GFR
<10 ml/min – 15 mg/kg every 48 hours
|
|
LIVER
IMPAIRMENT DOSE
|
N/A
|
|
PREGNANCY
|
Max
15 mg/kg/day
|
|
LACTATION
|
No
known adverse effects
|
|
BUILDING
A REGIMEN
|
|
ORAL
AGENTS
– 2nd
line
|
NAME
|
ETHIONAMIDE
(Bacteriostatic)
|
|
DOSE/KG
|
15-20
mg/kg/day
|
|
USUAL
DOSE
|
1000
mg
dly
(Split
dose
250
mg
mane,
750
mg
nocte
to
minimize
nausea)
|
|
MAXIMUM
DOSE
|
1000
mg
dly
|
|
CAUTION
|
Hepatic
disease, previous hypersensitivity to Ethionamide or porphyria.
Use with caution in diabetes, alcoholics, psychiatric illness,
depression, hypothyroidism and epilepsy
|
|
COMMON
SIDE EFFECTS
|
GI
side effects, CNS toxicity, Hepatotoxicity
|
|
PAEDIATRIC
DOSE
|
10
mg/kg/day
|
|
RENAL
DOSE
|
GFR
<30
ml/min
or
on
dialysis
– Decrease
dose
by
50%
|
|
LIVER
IMPAIRMENT DOSE
|
N/A
|
|
PREGNANCY
|
Category
C.
Teratogenic
in
animals.
Avoid
|
|
LACTATION
|
Safety
not established
|
|
BUILDING
A REGIMEN
|
|
|
NAME
|
CYCLOSERINE
(AND
TERIZIDONE
– a
derivative
of
Cycloserine)
(Bacteriostatic)
|
|
DOSE/KG
|
10-20
mg/kg/day.
+
Pyridoxine
to
prevent
CNS
Side
effects
|
|
USUAL
DOSE
|
500-750
mg
dly
or
250-500
mg
bd
|
|
MAXIMUM
DOSE
|
1000
mg dly
|
|
CAUTION
|
Contraindicated
in psychiatric conditions, epilepsy, severe renal impairment,
alcohol abuse and porphyria. Caution in elderly and those with
renal impairment
|
|
COMMON
SIDE EFFECTS
|
CNS
toxicity
(more
common
with
Cycloserine),
skin
rash
|
|
PAEDIATRIC
DOSE
|
10
mg/kg/day
|
|
RENAL
DOSE
|
Extend
dose interval and adjust by monitoring drug levels (Target –
20-30micromg/ml)
GFR
10-50
ml/min
– Extend
dosing
interval
to
24
hrs
GFR
<10 ml/min – Extend dosing interval to 36-48 hrs
|
|
LIVER
IMPAIRMENT DOSE
|
N/A
|
|
PREGNANCY
|
Use
only
if
no
alternatives
|
|
LACTATION
|
Give
infant Pyridoxine
|
|
BUILDING
A REGIMEN
|
Does
not share cross-resistance with other anti-TB drugs
|
|
NAME
|
PARA-AMINO
SALICYLIC
ACID
(PAS)
|
|
DOSE/KG
|
150
mg/kg/day or 10-12 g/day in 2 divided doses
|
|
USUAL
DOSE
|
5
g bd
|
|
MAXIMUM
DOSE
|
12
g/day
|
|
CAUTION
|
Allergy
to aspirin or PAS. Avoid in advance renal impairment
|
|
COMMON
SIDE EFFECTS
|
Anorexia,
diarrhoea, hypothyroidism. Low risk of hepatitis
|
|
PAEDIATRIC
DOSE
|
150
mg/kg/day in 2 or 3 divided doses
|
|
RENAL
DOSE
|
Avoid
|
|
LIVER
IMPAIRMENT DOSE
|
N/A
|
|
PREGNANCY
|
Avoid
|
|
LACTATION
|
Concentrations
excreted in breast milk are low
|
|
BUILDING
A REGIMEN
|
|
FLUOROQUINOLONES
– 2nd
line
|
NAME
|
LEVOFLOXACIN
(Bactericidal)
|
|
DOSE/KG
|
–
|
|
USUAL
DOSE
|
750
mg dly
|
|
MAXIMUM
DOSE
|
750
mg dly
|
|
CAUTION
|
As
for Ciprofloxacin
|
|
COMMON
SIDE EFFECTS
|
As
for Ciprofloxacin.
|
|
PAEDIATRIC
DOSE
|
7.5-10
mg/kg/day (Max 750 mg)
|
|
RENAL
DOSE
|
GFR
<30 ml/min – 750-1000mg 3 times/week
|
|
LIVER
IMPAIRMENT DOSE
|
N/A
|
|
PREGNANCY
|
Avoid
|
|
LACTATION
|
Avoid
|
|
BUILDING
A REGIMEN
|
|
|
NAME
|
OFLOXACIN
(Bactericidal)
|
|
DOSE/KG
|
–
|
|
USUAL
DOSE
|
800
mg dly or 400 mg bd
|
|
MAXIMUM
DOSE
|
800
mg dly
|
|
CAUTION
|
Avoid
in patients with prolonged QT interval. Previous hypersensitivity
to fluoroquinolones. Caution in patients with CNS disorders,
hepatic or renal involvement and in children
|
|
COMMON
SIDE EFFECTS
|
GI
side effects, Headaches, dizziness, drowsiness, insomnia,
arthralgia. Hypersensitivity
|
|
PAEDIATRIC
DOSE
|
15-20
mg/kg/day
|
|
RENAL
DOSE
|
GFR
<30 ml/min – 800 mg 3 times/week
|
|
LIVER
IMPAIRMENT DOSE
|
N/A
|
|
PREGNANCY
|
Avoid
|
|
LACTATION
|
Avoid
|
|
BUILDING
A REGIMEN
|
|
|
NAME
|
CIPROFLOXACIN
(Bactericidal)
|
|
DOSE/KG
|
–
|
|
USUAL
DOSE
|
500-750
mg bd (Doses at higher range preferred in TB)
|
|
MAXIMUM
DOSE
|
750
mg bd
|
|
CAUTION
|
Avoid
in patients with prolonged QT interval. Previous hypersensitivity
to fluoroquinolones. Caution in patients with CNS disorders,
hepatic or renal involvement and in children
|
|
COMMON
SIDE EFFECTS
|
GI
side effects, Headaches, dizziness, drowsiness, insomnia,
arthralgia. Hypersensitivity
|
|
PAEDIATRIC
DOSE
|
20-30
mg/kg/day in 2 divided doses
|
|
RENAL
DOSE
|
GFR
<30 ml/min – 1000-1500 mg 3 times/week
|
|
LIVER
IMPAIRMENT DOSE
|
N/A
|
|
PREGNANCY
|
Avoid
|
|
LACTATION
|
Avoid
|
|
BUILDING
A REGIMEN
|
|
|
NAME
|
MOXIFLOXACIN
(Bactericidal)
|
|
DOSE/KG
|
–
|
|
USUAL
DOSE
|
400
mg dly
|
|
MAXIMUM
DOSE
|
400
mg dly
|
|
CAUTION
|
As
for Ciprofloxacin
|
|
COMMON
SIDE EFFECTS
|
As
for Ciprofloxacin
|
|
PAEDIATRIC
DOSE
|
7.5-10
mg/kg/day (Max 400 mg)
|
|
RENAL
DOSE
|
No
dose adjustment
|
|
LIVER
IMPAIRMENT DOSE
|
N/A
|
|
PREGNANCY
|
Avoid
|
|
LACTATION
|
Avoid
|
|
BUILDING
A REGIMEN
|
|
INJECTABLE
AGENTS
|
NAME
|
STREPTOMYCIN
(Bactericidal)
|
|
DOSE/KG
|
15-20
mg/kg/day
IMI
|
|
USUAL
DOSE
|
750
mg dly IMI
|
|
MAXIMUM
DOSE
|
1000
mg dly IMI
|
|
CAUTION
|
Patients
with renal failure, impaired hearing or vestibular defects,
previous hypersensitivity to Streptomycin. Contraindicated in
myasthenia gravis
|
|
COMMON
SIDE EFFECTS
|
Ototoxicity,
renal toxicity, hypersensitivity, skin rash
|
|
PAEDIATRIC
DOSE
|
20-40
mg/kg/day
|
|
RENAL
DOSE
|
GFR
10-50 ml/min – 15 mg/kg every 24-72 hours
GFR
<10 ml/min – 15 mg/kg every 72-96 hours
|
|
LIVER
IMPAIRMENT DOSE
|
N/A
|
|
PREGNANCY
|
Can
cause ototoxicity in foetus – avoid
|
|
LACTATION
|
No
known adverse effects
|
|
BUILDING
A REGIMEN
|
|
|
NAME
|
KANAMYCIN
(Bactericidal)
|
|
DOSE/KG
|
15
mg/kg/day
IMI
|
|
USUAL
DOSE
|
750-1000
mg dly IMI
|
|
MAXIMUM
DOSE
|
1500
mg dly IMI
|
|
CAUTION
|
Patients
with renal failure, impaired hearing or vestibular defects,
previous hypersensitivity to Kanamycin. Contraindicated in
myasthenia gravis
|
|
COMMON
SIDE EFFECTS
|
Ototoxicity,
renal toxicity, hypersensitivity, skin rash
|
|
PAEDIATRIC
DOSE
|
15-30
mg/kg/day
|
|
RENAL
DOSE
|
GFR
<30 ml/min – 12-15 mg/kg 2-3 times/week
|
|
LIVER
IMPAIRMENT DOSE
|
N/A
|
|
PREGNANCY
|
Avoid
|
|
LACTATION
|
No
known adverse effects
|
|
BUILDING
A REGIMEN
|
Vs
Amikacin – As effective, less well tolerated, cheaper
Vs
Streptomycin – Streptomycin-resistant strains usually susceptible
to Kanamycin and Amikacin
|
|
NAME
|
AMIKACIN
(Bactericidal)
|
|
DOSE/KG
|
15-20
mg/kg/day
IMI
|
|
USUAL
DOSE
|
750-1000
mg dly IMI
|
|
MAXIMUM
DOSE
|
1500
mg dly IMI
|
|
CAUTION
|
Patients
with renal failure, impaired hearing or vestibular defects,
previous hypersensitivity to Amikacin. Contraindicated in
myasthenia gravis. Caution in neonates
|
|
COMMON
SIDE EFFECTS
|
Ototoxicity,
renal toxicity, peripheral neuropathy, hypersensitivity, skin rash
|
|
TARGET
DRUG LEVELS
|
Peak
> 30 mg/L; trough < 1 mg/L
|
|
PAEDIATRIC
DOSE
|
<10
years – 25 mg/kg dly on first day; then 18 mg/kg dly
>10
years
– 20
mg/kg
dly
on
first
day;
then
15
mg/kg
dly
|
|
RENAL
DOSE
|
GFR
<60
ml/min
– Loading
dose
10
mg/kg
with
further
doses
guided
by
drug
levels
|
|
LIVER
IMPAIRMENT DOSE
|
N/A
|
|
PREGNANCY
|
Avoid
|
|
LACTATION
|
No
known adverse effects
|
|
BUILDING
A REGIMEN
|
Vs
Kanamycin – As effective, better tolerated, more expensive
Vs
Streptomycin – Streptomycin-resistant strains usually susceptible
to Kanamycin and Amikacin
|
Resources:
-
Schaaf
H,
Zumla
AI
et
al.
Tuberculosis:
A
Comprehensive
Clinical
Reference.
Elsevier
2009.
-
South
African Medicines Formulary. Produced by the Division of Clinical
Pharmacology, University of Cape Town.